TGFB1 and renal cell carcinoma: Treatment of RCC cells with TGF-β1 inhibits expressions of miR-30a-5p and miR-328 while increasing miR-25-3p levels, contributing to an altered expression of adhesion proteins, including COL5A1 and ITGA5, and changes in the adhesive properties of ccRCC cells.